Cited by 75Clinical Nutrition and GastroenterologyNutrition and Health in AgingHealth Systems, Economic Evaluations, Quality of Life

Cost-effectiveness of a 3-month intervention with oral nutritional supplements in disease-related malnutrition: a randomised controlled pilot study

Open access
Norman, K, Pirlich, M, Smoliner, C, Kilbert, A, Schulzke, J D, Ockenga, J, Lochs, H, Reinhold, T·2011·European Journal of Clinical Nutrition

Abstract

Background/objectives Nutritional intervention with oral nutritional supplements (ONS) has been shown to increase quality of life in malnourished patients. We investigated whether post-hospital supplementation with ONS is cost-effective according to international benchmarks in malnourished patients. Subjects/methods In total, 114 malnourished patients (50.6±16.1 years, 57 female) with benign gastrointestinal disease were included and randomised to receive either ONS for 3 months and dietary counselling at discharge (intervention, n=60) or only dietary counselling at discharge (control group, n=54). Nutritional status was assessed with Subjective Global Assessment. Intervention patients documented daily intake of ONS; quality of life was assessed with Short-Form (SF)-36 Health Survey and SF-36 values were transformed into health-status utilities. Quality-adjusted life years (QALYs) were calculated by adopting the area under the curve method. We used two different pricing scenarios for ONS (minimum price: [euro]2.30 and maximum: [euro]2.93/tetrapack). The incremental cost-effectiveness ratio (ICER) of supplementation with ONS was calculated for both price scenarios. All analyses were corrected for age and gender. Results Intervention patients consumed 2.4±0.8 ONS per day. Intervention and control patients did not differ in their health status utilities at baseline (0.594±0.017 vs 0.619±0.018), but after 3 months, the health status utilities were significantly higher in intervention patients than in control patients (0.731±0.015 vs 0.671±0.016, P=0.028). Intervention was associated with significantly higher costs (ICER: [euro]9497 and [euro]12,099/additional QALY, respectively) but deemed cost-effective according to international thresholds (< [euro]50,000/QALY). Conclusions A 3-month intervention with ONS increases quality of life in malnourished patients. This treatment appears to be cost-effective according to international benchmarks.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ejcn.2011.31

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In younger malnourished patients (50.6±16.1 years) with benign gastrointestinal or liver disease who received ONS during hospital stay and for three months post discharge, QoL assessed by SF-36 was significantly improved in IG compared to CG (mean improvement at three months 0.128, 95% CI 0.095 to 0.161 in IG vs 0.067, 95% CI 0.031 to 0.103 in CG).

    “In younger malnourished patients (50.6 ± 16.1 years) with benign gastrointestinal or liver disease who received ONS during their hospital stay and for three months post discharge, QoL assessed by the 36-Item Short Form Health Survey questionnaire was significantly improved in the IG patients (n ¼ 60) compared to the CG patients (n ¼ 54) (mean improvement at three months was 0.128, 95% CI 0.095 to”

    From ESPEN guideline on nutritional support for polymorbid medical inpatients (2023) · cites this paper as [123]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Lochs H. ESPEN Guidelines on adult enteral nutrition Clinical Nutrition 2006;25:177- 360
  2. Lothgren M, Zethraeus N. Definition, interpretation and calculation of cost- effectiveness acceptability curves. Health Econ 2000;9:623-30.

Cited by

Sorted by citations

Authors
Norman, K., Pirlich, M., Smoliner, C., Kilbert, A., Schulzke, J. D., Ockenga, J., Lochs, H., & Reinhold, T.
Affiliations
  • Stiftung Charité (DE)
  • Charité – Universitätsmedizin Berlin (DE)
  • Klinikum Bremen-Mitte (DE)
Corresponding author
Norman, K
Venue
European Journal of Clinical Nutrition
Published
2011-03-16
Volume
65
Issue
6
Pages
735-742
ISSN
  • 0954-3007 (ISSN-L)
  • 1476-5640
OpenAlex
W2159869190
Cited by
75
References
32
Citations by year
2026: 1 · 2025: 5 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 5 · 2019: 6 · 2018: 5 · 2017: 4 · 2016: 2 · 2015: 8 · 2014: 9 · 2013: 6 · 2012: 4
FWCI
5.83
Type
journal article
Language
en
Open access
Locations
  • European Journal of Clinical Nutrition (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
oral nutritional supplements, disease-related malnutrition, cost-effectiveness, benign gastrointestinal disease, quality of life, quality-adjusted life years, nutrition counseling, incremental cost-effectiveness ratio
MeSH terms
Adult, Energy Intake, Cost-Benefit Analysis, Dietary Proteins, Female, Gastrointestinal Diseases, Health Status, Humans, Male, Middle Aged, Pilot Projects, Quality of Life, Treatment Outcome, Quality-Adjusted Life Years, Area Under Curve, Dietary Supplements, Malnutrition, Nutrition Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review